Clinical Trial

Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is: Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-20
Trial Details
NCT Number NCT07381296
Lead Sponsor Sohag University
Conditions Rheumatoid Arthritis Disease Flare
Enrollment 200 participants
Start Date 2026-02-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-19